Tempest Therapeutics, Inc. Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
Tempest Therapeutics, Inc. (TPST) had Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount of $5.20 million as of 2021-03-31, per its 10-Q filed 2021-05-13.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions · last filed 2021-05-13
- 2021-03-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $5.20M.
- 2020-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $8.10M.
- 2020-09-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $9.10M.
- 2020-06-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $10.20M.
| Period end | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount |
|---|---|
| 2021-03-31 | $5.20M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $8.10M 10-K · filed 2021-03-29 |
| 2020-09-30 | $9.10M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $10.20M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $12.50M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $9.20M 10-K · filed 2020-03-11 |
| 2019-09-30 | $10.40M 10-Q · filed 2019-11-13 |
| 2019-06-30 | $12.10M 10-Q · filed 2019-08-12 |
| 2019-03-31 | $10.40M 10-Q · filed 2019-05-15 |
| 2018-12-31 | $6.80M 10-K · filed 2019-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |